Aktivita CYP2D6 u pacientů léčených risperidonem

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English CYP2D6 testing in patients treated with risperidone
Authors

BARTEČEK Richard JUŘICA Jan ZRŮSTOVÁ Jana PINDUROVÁ Eva KAŠPÁREK Tomáš ŽOURKOVÁ Alexandra

Year of publication 2011
Type Article in Periodical
Magazine / Source Česká a slovenská psychiatrie
MU Faculty or unit

Faculty of Medicine

Citation
Field Other medical specializations
Keywords pharmacogenetics; cytochrome P450; CYP2D6; risperidone; 9-hydroxy-risperidone
Description There is significant interindividual variability in patient reactivity to psychopharmacological treatment. Possibility to predict patient’s response to pharmacological treatment is the focus of pharmacogenetics. One of the promising candidates for pharmacogenetic testing is CYP2D6, enzyme metabolising several psychoactive drugs including antipsychotic risperidone. Risperidone and its metabolite 9-OH-risperidone show considerable differences, one of which is poorer blood-brain barrier permeability of 9-OH-risperidone. CYP2D6 activity can be estimated by genotypization and phenotypization. Phenotypization is able to determine actual level of enzyme activity even if the CYP2D6 activity has been reduced by CYP2D6 inhibitors. Four CYP2D6 phenotypic variants exist. The most frequent is extensive metaboliser. Intermediate metaboliser and poor metaboliser have reduced CYP2D6 activity and according to number of studies there is higher possibility and severity of risperidone adverse effects. The last variety of CYP2D6 phenotype is ultra-rapid metaboliser with possible lower risperidone efficacy. Besides the high number of studies demonstrating effect of CYP2D6 variability, there are studies which did not show its significant impact. Exact amount of CYP2D6 variability effect is therefore still unclear and further studies has to be conducted to find out whether CYP2D6 pharmacological testing has its place in clinical setting.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.